Brian Wiley
2017
In 2017, Brian Wiley earned a total compensation of $1M as Chief Commercial Officer at NewLink Genetics, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $105,100 |
|---|---|
| Option Awards | $547,341 |
| Salary | $356,442 |
| Other | $29,992 |
| Total | $1,038,875 |
Wiley received $547.3K in option awards, accounting for 53% of the total pay in 2017.
Wiley also received $105.1K in non-equity incentive plan, $356.4K in salary and $30K in other compensation.
Rankings
In 2017, Brian Wiley's compensation ranked 8,807th out of 14,666 executives tracked by ExecPay. In other words, Wiley earned more than 39.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,807 out of 14,666 | 40th |
Division Manufacturing | 3,360 out of 5,772 | 42nd |
Major group Chemicals And Allied Products | 1,140 out of 2,075 | 45th |
Industry group Drugs | 907 out of 1,731 | 48th |
Industry Pharmaceutical Preparations | 712 out of 1,333 | 47th |
Source: SEC filing on April 9, 2018.
Wiley's colleagues
We found four more compensation records of executives who worked with Brian Wiley at NewLink Genetics in 2017.